Furthermore, the difference was marginally significant when we excluded patients with any other non‐diabetes mellitus comorbidities, suggesting an association of pre‐existing diabetes mellitus itself with a reduction of the implementation rate of adjuvant chemotherapy.
← all excerpts
Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer.
1
—
—